Tag: hypertension

SoniVie announces successful procedure with Tivus system on first patient enrolled...

SoniVie today announced that on 30 May this year the first patient was treated with its renal artery denervation Tivus therapeutic intravascular ultrasound technology, as...
SonieVie

SoniVie receives FDA IDE approval for pilot study to treat hypertension...

SoniVie recently announced that on 5 May 2022 the US Food and Drug Administration (FDA) granted investigational device exemption (IDE) approval for its REDUCED1...

Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study

Medtronic today announced findings from a new study of patient preferences for the treatment of hypertension. The findings are set to be presented during...

ESH position paper highlights renal denervation as a third option for...

The European Society of Hypertension (ESH) has presented an updated position paper on renal denervation (RDN) in a pre-ESH congress satellite symposium (10–11 September,...

Virtual ACC: Renal denervation bests sham control to safely lower blood...

Three months after undergoing renal denervation, patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared...

TARGET BP I trial enrols its first patient

The first patient has been randomised in the TARGET BP I trial at the Piedmont Heart Institute in Atlanta, USA, to investigate the use...

First procedure performed in Rox Medical’s CONTROL HTN-2 clinical trial

The first patient was treated in the CONTROL hypertension (HTN)-2 clinical study, the Rox Medical’s pivotal study to evaluate the safety and effectiveness of...